CIK 0001800315 · Non-accelerated filer<br>Smaller reporting company
Damora Therapeutics, Inc.
Sign in to watch- Ticker
- DMRA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 371957007
- Phone
- (781) 281-9020
- Business address
- 100 FIFTH AVENUE, SUITE 700, WALTHAM, MA, 02451
- Former names
- Galecto, Inc., Galecto Inc.
- Open-market buys, last 90 days
- $252,875
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$252,875. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-11-09 | Schambye Hans T. Chief Executive Officer | Purchase | +4,500 | $3.50 | $16K | 47,428 |
| 2021-11-08 | Freve Jonathan Chief Financial Officer | Purchase | +3,000 | $3.40 | $10K | 8,000 |
| 2021-08-18 | Freve Jonathan Chief Financial Officer | Purchase | +3,000 | $3.92 | $12K | 5,000 |
| 2021-06-28 | Lindmark Bertil Chief Medical Officer | Purchase | +2,000 | $5.26 | $11K | 2,000 |
| 2021-06-24 | Schambye Hans T. Chief Executive Officer | Purchase | +3,000 | $5.11 | $15K | 42,928 |
| 2021-06-23 | Freve Jonathan Chief Financial Officer | Purchase | +2,000 | $4.74 | $9K | 2,000 |
| 2021-06-23 | Winslow Garrett General Counsel | Purchase | +2,000 | $4.80 | $10K | 2,000 |
| 2021-06-15 | Winslow Garrett General Counsel | Grant or award · Stock Option (right to buy) | +120,000 | 120,000 | ||
| 2021-05-26 | Prener Anne Director | Grant or award · Stock Option (right to buy) | +18,000 | 18,000 | ||
| 2021-05-26 | Khuong Chau Quang Director | Grant or award · Stock Option (right to buy) | +18,000 | 18,000 | ||
| 2021-05-26 | Dallas Jayson Donald Alexander Director | Grant or award · Stock Option (right to buy) | +18,000 | 18,000 | ||
| 2021-05-26 | GOLDFISCHER CARL Director | Grant or award · Stock Option (right to buy) | +18,000 | 18,000 | ||
| 2021-01-08 | Prener Anne Director | Grant or award · Stock Option (right to buy) | +18,000 | 18,000 | ||
| 2021-01-08 | Prener Anne Director | Grant or award · Stock Option (right to buy) | +6,000 | 6,000 | ||
| 2021-01-05 | Pedersen Anders Chief Operating Officer | Grant or award · Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2021-01-05 | Schambye Hans T. Chief Executive Officer | Grant or award · Stock Option (right to buy) | +230,000 | 230,000 | ||
| 2021-01-05 | Lindmark Bertil Chief Medical Officer | Grant or award · Stock Option (right to buy) | +95,000 | 95,000 | ||
| 2021-01-05 | Freve Jonathan Chief Financial Officer | Grant or award · Stock Option (right to buy) | +95,000 | 95,000 | ||
| 2020-11-19 | Dallas Jayson Donald Alexander Director | Grant or award · Stock Option (right to buy) | +18,000 | 18,000 | ||
| 2020-11-19 | Dallas Jayson Donald Alexander Director | Grant or award · Stock Option (right to buy) | +9,000 | 9,000 |
Page 8 of 12 · 227 trades